Applied Therapeutics (APLT) Return on Capital Employed (2023 - 2025)
Historic Return on Capital Employed for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to 33.29%.
- Applied Therapeutics' Return on Capital Employed fell 282200.0% to 33.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.29%, marking a year-over-year decrease of 282200.0%. This contributed to the annual value of 2.4% for FY2024, which is N/A changed from last year.
- Per Applied Therapeutics' latest filing, its Return on Capital Employed stood at 33.29% for Q3 2025, which was down 282200.0% from 3.79% recorded in Q2 2025.
- Applied Therapeutics' Return on Capital Employed's 5-year high stood at 3.05% during Q4 2023, with a 5-year trough of 33.29% in Q3 2025.
- Its 3-year average for Return on Capital Employed is 5.93%, with a median of 2.91% in 2025.
- Within the past 5 years, the most significant YoY rise in Applied Therapeutics' Return on Capital Employed was 18900bps (2025), while the steepest drop was -282200bps (2025).
- Applied Therapeutics' Return on Capital Employed (Quarter) stood at 3.05% in 2023, then tumbled by -149bps to 1.5% in 2024, then plummeted by -2113bps to 33.29% in 2025.
- Its Return on Capital Employed was 33.29% in Q3 2025, compared to 3.79% in Q2 2025 and 2.02% in Q1 2025.